NCT05984017|Unknown
A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma
A Non-interventional Study and Its Clinical Relevance With Advanced Lung Squamous Cell Carcinoma
Loading search results
A Non-interventional Study and Its Clinical Relevance With Advanced Lung Squamous Cell Carcinoma
Sponsor study identifier
observational
130
1 country
1
Study Start
July 1, 2021
Actual (reported)Primary Completion
December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1, 2021
Actual (reported)July 31, 2023
Actual (reported)August 9, 2023
Actual (reported)December 31, 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
progression-free survival
From registration onto that step until death, or censored at the date of last contact.
2 years
Overall survival
From registration onto that step until death, or censored at the date of last contact.
2 years
No drug intervention or tissue sampling will be included in this study.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
advanced or metastatic (stage IV) lung squamous cell carcinoma
Yongchang Zhang
Changsha, Hunan, 410013, China
needle biopsy for samples with DNA
Yongchang Zhang, MD
Hunan Cancer Hospital
First Submitted
July 31, 2023
First Posted
August 9, 2023
Study Start
July 1, 2021
Actual (reported)Primary Completion
December 31, 2024
Estimated (date passed)Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 10, 2024
Record last verified: 2024-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: